Two in three adults in England are overweight or obese - and 26 per cent of us have learned all we know about treatments like ...

In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...

The death of a Scottish nurse as a result of complications after taking the drug Mounjaro for weight loss has highlighted the potential dangers ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.

Weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound are seen as game-changers for obesity and weight ...

GLP-1 drugs have been linked to numerous potential health benefits like treatment of existing conditions including heart ...

A new study has found that the groundbreaking new class of weight loss drugs may not only be good at treating diabetes, but ...

Doctors say they have not seen anything like this since the emergence of statins to lower cholesterol. But do we know enough ...

The popular weight loss drugs have also been found to reduce other risks, including the risk of death from COVID-19.

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

Both Wegovy and Mounjaro have now been approved for treating obesity on the NHS, and the Government has announced ambitious plans to offer them to thousands of people who are unable to work with ...